Cytalux
NDC 81052-138, Pafolacianine injection, injection, from On Target Laboratories, Inc..
- Product NDC
- 81052-138
- Status
- Listed
- Labeler
- On Target Laboratories, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214907
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81052-138 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PAFOLACIANINE SODIUM3.2 mg/1.6mL
Pharmacologic classes
Fluorescence Contrast Activity [MoA]; Optical Imaging Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81052-138-10 | 81052013810 | 10 CARTON in 1 CARTON (81052-138-10) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 1.6 mL in 1 VIAL, SINGLE-DOSE (81052-138-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/d21952b9-7c4e-3a56-e053-2a95a90a0ab0
Use it
Look up 81052-138 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81052-138 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81052-138. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.